Innovative freeze-drying technique in the fabrication of dissolving microneedle patch: Enhancing transdermal drug delivery efficiency.

Autor: Su T; Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai, People's Republic of China., Tang Z; Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai, People's Republic of China., Hu J; Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai, People's Republic of China., Zhu Y; Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai, People's Republic of China., Shen T; Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai, People's Republic of China. shenteng@fudan.edu.cn.; Key Laboratory of Smart Drug Delivery, Ministry of Education, Shanghai, 201203, People's Republic of China. shenteng@fudan.edu.cn.
Jazyk: angličtina
Zdroj: Drug delivery and translational research [Drug Deliv Transl Res] 2024 Nov; Vol. 14 (11), pp. 3112-3127. Date of Electronic Publication: 2024 Mar 02.
DOI: 10.1007/s13346-024-01531-y
Abstrakt: Microneedle patch (MNP) has become a hot research topic in the field of transdermal drug delivery due to its ability to overcome the stratum corneum barrier. Among the various types of microneedles, dissolving microneedles represent one of the most promising transdermal delivery methods. However, the most used method for preparing dissolving microneedles, namely microfabrication, suffers from issues such as long drying time, susceptibility to humidity, and large batch-to-batch variability, which limit the development of dissolving microneedles. In this study, we report for the first time a method for preparing dissolving microneedles using freeze-drying technology. We screened substrates suitable for freeze-dried microneedle patch (FD-MNP) and used coating technology to enhance the mechanical strength of FD-MNP, allowing them to meet the requirements for skin penetration. We successfully prepared FD-MNP using hyaluronic acid as the substrate and insulin as the model drug. Scanning electron microscopy revealed that the microneedles had a porous structure. After coating, the mechanical strength of the microneedles was 0.61 N/Needle, and skin penetration rate was 97%, with a penetration depth of 215 μm. The tips of the FD-MNP dissolved completely within approximately 60 s after skin penetration, which is much faster than conventional MNP (180 s). In vitro transdermal experiments showed that the FD-MNP shortened the lag time for transdermal delivery of rhodamine 123 and insulin compared to conventional MNP, indicating a faster transdermal delivery rate. Pharmacological experiments showed that the FD-MNP lowered mouse blood glucose levels more effectively than conventional MNP, with a relative pharmacological availability of 96.59 ± 2.84%, higher than that of conventional MNP (84.34 ± 3.87%), P = 0.0095. After storage under 40℃ for two months, the insulin content within the FD-MNP remained high at 95.27 ± 4.46%, which was much higher than that of conventional MNP (58.73 ± 3.71%), P < 0.0001. In conclusion, freeze-drying technology is a highly valuable method for preparing dissolving microneedles with potential applications in transdermal drug delivery.
(© 2024. Controlled Release Society.)
Databáze: MEDLINE
Externí odkaz: